New therapies could stop antibiotic-induced damage to gut health
Researchers determined the concentrations at which a specific antibiotic would affect certain strains for more than 800 antibiotic–strain combinations.
Gut Repair
Carbon monoxide for Crohn’s disease? Low doses could reduce inflammation, study shows
Since the 1990s, Leo Otterbein, a professor of surgery at Harvard Medical School and Beth Israel Deaconess Medical Center has been studying the effects of low-dose carbon monoxide.
Harvard scientists propose widespread banking of stool samples for fecal transplants later in life
Researchers from the Harvard Medical School and Brigham and Women’s Hospital are proposing the widespread banking of stool samples for fecal transplants later in life.
Fecal transplants could protect newborns from antibiotics that killed ‘good’ gut bacteria, study finds
Fecal transplants could potentially protect newborns who received antibiotics that killed “good” gut bacteria
How amoeba therapy could stop bacteria behind severe diarrheal infections in children
If successful, Dr. Moonah’s work would be the first to deliver a drug treatment using an amoeba or another protozoan.
Blood cell discovery may lead to new treatments for chronic inflammatory conditions
Neutrophils, a type of white blood cell, fight infection, clear away cell debris, and heal injured tissue. In diseases with chronic or excessive inflammation (e.g., arthritis, sepsis), however, they can also cause tissue damage. Scientists at the University of Illinois, Chicago, recently identified two distinct subtypes of neutrophils, and designed a way to preserve the neutrophils’ favorable effects while their anti-inflammatory properties fight disease.
New nitric oxide therapy could reverse obesity effects, prevent metabolic disorders
A therapy involving the continuous release of nitric oxide could help with obesity and related conditions like Type 2 diabetes.
Innovative liver regeneration therapy could lead to breakthrough treatments for cancer, disease
Scientists at the Salk Institute for Biological Studies in San Diego discovered that the use of reprogramming molecules can improve cell growth and speed liver regeneration.
Gut microbes help regulate pancreas, hormone production within GI tract
A recent study may lead to new gut microbiome-based therapies to normalize function of the pancreas and GI tract hormones in obese diabetes patients.
Study finds new, promising target for IBD treatment
New research suggests there is a way to optimize treatments for inflammatory bowel disease, or IBD.